Activation of plasminogen through surface-mediated reactions is well recognized. In the presence of kaolin, purified Hageman factor (Factor XII) changed plasminogen to plasmin, as assayed upon a synthetic amide substrate and by fibrinolysis. Kinetic studies suggested an enzymatic action of Hageman factor upon its substrate, plasminogen. Hageman factor fragments, at a protein concentration equivalent to whole Hageman factor, activated plasminogen to a lesser extent. These protein preparations were not contaminated with other agents implicated in surface-mediated fibrinolysis. Diisopropyl fluorophosphate treatment of plasminogen did not inhibit its activation by Hageman factor. These studies indicate that Hageman factor has a hitherto unsuspected function, the direct activation of plasminogen.
G H Goldsmith Jr, H Saito, O S Ratnoff
Year: | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1976 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 1 | 2 | 1 | 1 | 1 | 5 | 3 | 1 | 3 | 3 | 3 | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 3 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 3 | 4 | 6 | 3 | 3 | 3 | 2 | 4 | 4 | 1 | 95 |
Title and authors | Publication | Year |
---|---|---|
The complex role of kininogens in hereditary angioedema.
Kaplan AP, Joseph K, Ghebrehiwet B |
2022 | |
Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema
S de Maat, K Joseph, C Maas, AP Kaplan |
Clinical Reviews in Allergy & Immunology | 2021 |
Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies
Gando S, Wada T |
Frontiers in immunology | 2021 |
Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery
A Miszta, HK Ahmadzia, NL Luban, S Li, D Guo, LA Holle, JS Berger, AH James, JV Gobburu, J van den Anker, B de Laat, AS Wolberg |
Journal of Thrombosis and Haemostasis | 2020 |
Factor XII - What's important but not commonly thought about
AH Schmaier, EX Stavrou |
Research and Practice in Thrombosis and Haemostasis | 2019 |
Hereditary angioedema: the plasma contact system out of control
SD Maat, ZL Hofman, C Maas |
Journal of Thrombosis and Haemostasis | 2018 |
Review: The mechanism of blood coagulation, its disorders and measurement in poultry
M Buzala, A Słomka, B Janicki, MB Ponczek, E Żekanowska |
Livestock Science | 2017 |
Platelets in Thrombotic and Non-Thrombotic Disorders
P Gresele, NS Kleiman, JA Lopez, CP Page |
Platelets in Thrombotic and Non-Thrombotic Disorders | 2017 |
Hemomath
A Fasano, A Sequeira |
Hemomath | 2017 |
Biophysical mechanisms of contact activation of blood-plasma clotting
VA Terenteva, AN Sveshnikova, MA Panteleev |
Biophysics | 2017 |
Global assays of fibrinolysis
A Ilich, I Bokarev, NS Key |
International Journal of Laboratory Hematology | 2017 |
Bradykinin: Inflammatory Product of the Coagulation System
Z Hofman, S Maat, CE Hack, C Maas |
Clinical Reviews in Allergy & Immunology | 2016 |
Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity
JL Mitchell, AS Lionikiene, G Georgiev, A Klemmer, C Brain, PY Kim, NJ Mutch |
Blood | 2016 |
Trauma Induced Coagulopathy
E Gonzalez, HB Moore, EE Moore |
2016 | |
The Role of Activated Coagulation Factor XII in overall Clot Stability and Fibrinolysis
J Konings, LR Hoving, RS Ariëns, EL Hethershaw, M Ninivaggi, LJ Hardy, B Laat, H Cate, H Philippou, JW Govers-Riemslag |
Thrombosis Research | 2015 |
Use of dextran sulfate in tourniquet-induced skeletal muscle reperfusion injury
C Duehrkop, J Denoyelle, S Shaw, R Rieben |
Journal of Surgical Research | 2014 |
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes |
2014 | |
Fluid-Structure Interaction and Biomedical Applications
T Bodnár, GP Galdi, Š Nečasová |
2014 | |
Handbook of Proteolytic Enzymes
FS Markland, S Swenson |
Handbook of Proteolytic Enzymes | 2013 |
Zinc: An important co-factor in haemostasis and thrombosis:
JI Weitz, JC Fredenburgh, T Vu |
Thrombosis and Haemostasis | 2013 |
C1 Esterase Inhibitor Reduces Lower Extremity Ischemia/Reperfusion Injury and Associated Lung Damage
C Duehrkop, Y Banz, R Spirig, S Miescher, MW Nolte, M Spycher, RA Smith, SH Sacks, R Rieben, M Moser |
PloS one | 2013 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Instabilities in fibrinolytic regulatory system. Theoretical analysis of blow-up phenomena
KG Guria, AR Gagarina, GT Guria |
Journal of Theoretical Biology | 2012 |
Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination
S Bhattacharya, VA Ploplis, FJ Castellino |
Journal of Biomedicine and Biotechnology | 2012 |
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné |
Advances in Immunology Volume 110 | 2011 |
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken |
Advances in Cancer Research Volume 110 | 2011 |
Comprehensive Toxicology
JM Sands, JW Verlander |
Comprehensive Toxicology | 2010 |
xPharm: The Comprehensive Pharmacology Reference
A Vinh |
xPharm: The Comprehensive Pharmacology Reference | 2010 |
Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro
A Tanaka, Y Suzuki, K Sugihara, N Kanayama, T Urano |
Life Sciences | 2009 |
Fundamental and Clinical Cardiology Series
PD Stein |
Cardiovascular Disease in the Elderly | 2008 |
Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema
AE Davis |
Annals of Allergy Asthma & Immunology | 2008 |
The plasma kallikrein-kinin system: its evolution from contact activation
AH Schmaier, KR Mccrae |
Journal of Thrombosis and Haemostasis | 2007 |
Kinetic analysis of the mechanism of plasminogen activation by streptokinase
ME Fuentes, E Valero, M García-Moreno, E Vique, R Varón |
Journal of Mathematical Chemistry | 2006 |
Mechanism of Angioedema in First Complement Component Inhibitor Deficiency
AE Davis |
Immunology and Allergy Clinics of North America | 2006 |
Molecular mechanisms of fibrinolysis
G Cesarman-Maus, KA Hajjar |
British Journal of Haematology | 2005 |
The effect of continuous-flow automated plateletpheresis on fibrinolytic activity of donor plasma
P Radziwon, B Boczkowska-Radziwon, A Lipska, M Smoktunowicz, J Kloczko |
Transfusion Medicine | 2005 |
The effect of leucocyte depletion on the quality of fresh-frozen plasma
R Cardigan, J Sutherland, M Garwood, P Krailadsiri, J Seghatchian, M Beard, N Beckman, LM Williamson |
British Journal of Haematology | 2001 |
Fibrinolytics and Antifibrinolytics
F Bachmann |
2001 | |
Platelets
JN George |
The Lancet | 2000 |
Fibrinolytic properties of activated FXII
EA Braat, G Dooijewaard, DC Rijken |
European Journal of Biochemistry | 1999 |
Antithrombin Agents: The New Class of Anticoagulant and Antithrombotic Drugs
J Fareed, BE Lewis, DD Callas, DA Hoppensteadt, JM Walenga, RL Bick |
Clinical and Applied Thrombosis/Hemostasis | 1999 |
ANTITHROMBIN AGENTS AS ANTICOAGULANTS AND ANTITHROMBOTICS
J Fareed, D Callas, DA Hoppensteadt, JM Walenga, RL Bick |
Medical Clinics of North America | 1998 |
Antithrombin Agents as Anticoagulants and Antithrombotics: Implications in Drug Development
J Fareed |
Clinical and Applied Thrombosis/Hemostasis | 1998 |
High Molecular Weight Kininogen Regulates Prekallikrein Assembly and Activation on Endothelial Cells: A Novel Mechanism for Contact Activation
G Motta, R Rojkjaer, AA Hasan, DB Cines, AH Schmaier |
Blood | 1998 |
Contact activation of plasmatic coagulation on polymeric membranes measured by the activity of kallikrein in heparinized plasma
TH Groth, J Synowitz, G Malsch, K Richau, W Albrecht, KP Lange, D Paul |
Journal of Biomaterials Science, Polymer Edition | 1997 |
The Kinin System
A Schmaier |
The Kinin System | 1997 |
Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes
RW Colman, AH Schmaier |
Blood | 1997 |
Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): Its relevance as a useful parameter for thein vitro assessment of haemodialysis membranes
BM Matata, JM Courtney, S Sundaram, S Wark, SK Bowry, J Vienken, GD Lowe |
Journal of Biomedical Materials Research | 1996 |
Activation of the contact and fibrinolytic systems after intravenous administration of endotoxin to normal human volunteers: correlation with the cytokine profile
RA Cadena, A Majluf-Cruz, A Stadnicki, JM Agosti, RW Colman, AF Suffredini |
Immunopharmacology | 1996 |
The influence of biomaterials on inflammatory responses to cardiopulmonary bypass
JM Courtney, BM Matata, HQ Yin, A Esposito, A Mahiout, DP Taggart, G Lowe |
Perfusion | 1996 |
In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents
BM Matata, S Wark, S Sundaram, JM Courtney, JD Gaylor, SK Bowry, J Vienken, GD Lowe |
Biomaterials | 1995 |
Physiology of Hemostasis
RL Bick, G Murano |
Clinics in Laboratory Medicine | 1994 |
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg |
1994 | |
C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2
CE Hack, AC Ogilvie, B Eisele, AJ Eerenberg, J Wagstaff, LG Thijs |
Intensive Care Medicine | 1993 |
Structural biology, cellular interactions and pathophysiology of the contact system
YT Wachtfogel, RA Cadena, RW Colman |
Thrombosis Research | 1993 |
One-step preparation of Hageman factor fragment concentrate
E Simonianová |
Biomedical Chromatography | 1992 |
Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII)
Z Toossi, JR Sedor, MA Mettler, B Everson, T Young, OD Ratnoff |
Proceedings of the National Academy of Sciences | 1992 |
Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo
M Levi, CE Hack, JP de Boer, DP Brandjes, HR Büller, JW Cate |
Journal of Clinical Investigation | 1991 |
Activation of the kallikrein-kinin system in plasma of some Brazilian snakes
BC Prezoto, E Hiraichi, FM Abdalla, ZP Picarelli |
Comparative Biochemistry and Physiology Part C: Comparative Pharmacology | 1991 |
F XII
G Fuhrer, MJ Gallimore, W Heller, |
Blut Zeitschrift für die Gesamte Blutforschung | 1990 |
Pharmacology of the Skin II
MW Greaves, S Shuster |
1989 | |
Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system
M Berrettini, RR Schleef, F España, DJ Loskutoff, JH Griffin |
The Journal of biological chemistry | 1989 |
Protein interactions with solid surfaces following contact with plasma and blood
JL Brash |
Makromolekulare Chemie. Macromolecular Symposia | 1988 |
Combined Effect of Transfusion and Blood Groups on the Survival of Patients With Breast Cancer. A Clinical Study of 901 Patients †
R Bufalino, A Morabito |
Vascular and endovascular surgery | 1988 |
The Molecular and Cellular Biology of Wound Repair
RA Clark, PM Henson |
1988 | |
The Fate of Fibrinogen following Adsorption at the Blood-Biomaterial, Interface
JL Brash |
Annals of the New York Academy of Sciences | 1987 |
Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary Bypass
W Oeveren, NJ Jansen, BP Bidstrup, D Royston, S Westaby, H Neuhof, CR Wildevuur |
The Annals of Thoracic Surgery | 1987 |
Neutral proteinases of the human intervertebral disc
J Melrose, P Ghosh, TK Taylor |
Biochimica et Biophysica Acta (BBA) - General Subjects | 1987 |
Coagulation and Fibrinolysis
IM Nilsson |
Scandinavian Journal of Gastroenterology | 1987 |
Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients
BL Zuraw, JG Curd |
Journal of Clinical Investigation | 1986 |
The contact activation system: Biochemistry and interactions of these surface-mediated defense reactions
RW Colman, AH Schmaier, OD Ratnoff |
Critical Reviews in Oncology/Hematology | 1986 |
Identification of proteins adsorbed from human plasma to glass bead columns: Plasmin-induced degradation of adsorbed fibrinogen
JL Brash, JA Thibodeau |
Journal of Biomedical Materials Research | 1986 |
Purification of human factor XII from plasma using zinc chelate affinity chromatography
RA Pixley, RW Colman |
Thrombosis Research | 1986 |
Kinins IV
LM Greenbaum, HS Margolius |
1986 | |
The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin
A Ichinose, K Fujikawa, T Suyama |
The Journal of biological chemistry | 1986 |
Degradation of adsorbed fibrinogen by surface-generated plasmin
JL Brash, BM Chan, P Szota, JA Thibodeau |
Journal of Biomedical Materials Research | 1985 |
Immunology of Rheumatic Diseases
S Gupta, N Talal |
1985 | |
Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa
DE Cool, CJ Edgell, GV Louie, MJ Zoller, GD Brayer, RT MacGillivray |
The Journal of biological chemistry | 1985 |
Surface-mediated defense reactions. The plasma contact activation system
RW Colman |
Journal of Clinical Investigation | 1984 |
Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor
A Agostini, HR Lijnen, RA Pixley, RW Colman, M Schapira |
Journal of Clinical Investigation | 1984 |
The fibrinolytic system in man
AP Reiner, WR Bell |
Critical Reviews in Oncology/Hematology | 1984 |
Induction of proteolytic activity in serum by treatment with anionic detergents and organic solvents
D Berger, TL Vischer, A Micheli |
Experientia | 1983 |
A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogen
LA Miles, JS Greengard, JH Griffin |
Thrombosis Research | 1983 |
The Physiology of Hemostasis
D Ogston |
1983 | |
INTERACTION OF THE CLOTTING, KININ-FORMING, COMPLEMENT, AND FIBRINOLYTIC PATHWAYS IN INFLAMMATION
AP Kaplan, M Silverberg, JT Dunn, B Ghebrehiwet |
Annals of the New York Academy of Sciences | 1982 |
An assessment of the fibrinolytic system in hemophilia A
ME Eyster, G Wahl, JO Ballard, J Sanders |
American Journal of Hematology | 1982 |
Comparative Studies on Human Activators of Plasminogen
M Mackie, NA Booth, B Bennett |
British Journal of Haematology | 1981 |
Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli
SP Leytus, LK Bowles, J Konisky, WF Mangel |
Proceedings of the National Academy of Sciences | 1981 |
Studies on plasminogen activator and other proteases in subcultured human vascular cells
GH Goldsmith, NP Ziats, AL Robertson |
Experimental and Molecular Pathology | 1981 |
Protection of human plasma kallikrein from inactivation by c.hivin.1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen
M Schapira, CF Scott, RW Colman |
Biochemistry | 1981 |
Enzymatic properties of human hageman factor fragment with plasma prekallikrein and synthetic substrates
Y Hojima, DL Tankersley, M Miller-Andersson, JV Pierce, JJ Pisano |
Thrombosis Research | 1980 |
Contemporary Hematology/Oncology
J LoBue, AS Gordon, R Silber, FM Muggia |
1980 | |
Pathogenese
H Cottier |
1980 | |
Kinetics of activation of human plasminogen by different activator species at pH 7.4 and 37 degrees C
RC Wohl, L Summaria, KC Robbins |
The Journal of biological chemistry | 1980 |
Mediators of inflammation
OD Ratnoff |
Journal of Allergy and Clinical Immunology | 1976 |